India introduces Qartemi a groundbreaking CAR-T cell therapy to fight advanced blood cancers like B-cell Non-Hodgkin Lymphoma ...
The new league phase of this season's expanded Champions League is all set for a frantic conclusion on Wednesday, as 18 ...
ITM's lutetium-containing therapy extended progression-free survival versus everolimus in patients with a specific kind of ...
The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status. Teliso-V ...
HMTM previously failed a phase 3 trial reported in 2016, and it remains to be seen whether the FDA will be swayed the LUCIDITY data without a comparison to control, especially given the ...
19h
NASCAR Clash road closures to block Winston-Salem nonprofit from opening parking lot to race fans President Trump and Elon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback